{"contacts": [{"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Bin Ma"}, {"accession": "MS:1000589", "name": "contact email", "value": "binma@uwaterloo.ca"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of Waterloo"}]}, {"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Zac Mc Donald"}, {"accession": "MS:1000589", "name": "contact email", "value": "zmcdonald@rapidnovor.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Rapid Novor Inc"}]}], "description": "The amino acid sequence of the M-protein for multiple myeloma is unique compared to the polyclonal antibodies in patients\u2019 blood. This uniqueness is exploited to develop an ultra-sensitive M-protein detection method utilizing mass spectrometry (MS). The method involves the de novo amino acid sequencing of the full-length M-protein, and a targeted MS/MS assay to detect and quantify the unique M-protein sequence in serum samples. Healthy control serum spiked with NISTmAb, and serial samples from an MM patient are used to demonstrate the ability of the platform to sequence and monitor a target M-protein. The de novo NISTmAb protein sequence obtained matched the published sequence, confirming the ability of the platform to accurately sequence a target M-protein in serum. NISTmAb was quantified down to 0.0002 g/dL in serum, hundreds of times more sensitive than conventional blood-based tests such as SPEP and IFE. The M-protein in the patient sample could be quantified throughout complete remission, demonstrating the utility of the assay to track M-protein considerably beyond the sensitivities of current blood-based tests. Notably, the assay detected molecular relapse 10 months before detection by IFE. The MS-based assay is highly sensitive, non-invasive and requires only a small amount of serum, less than 100 \u03bcl, to monitor M-protein levels in MM patients.", "fullDatasetLinks": [{"accession": "MS:1002873", "name": "Panorama Public dataset URI", "value": "https://panoramaweb.org/MMTech1.url"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD022980"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "1"}, {"accession": "MS:1002872", "name": "Panorama Public dataset identifier", "value": "https://panoramaweb.org/MMTech1.url"}], "instruments": [{"accession": "MS:1002732", "name": "Orbitrap Fusion Lumos"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "multiple myeloma"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "PRM"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "clinical proteomics"}], "modifications": [{"accession": "UNIMOD:27", "name": "Glu->pyro-Glu"}, {"accession": "UNIMOD:1", "name": "Acetyl"}, {"accession": "UNIMOD:28", "name": "Gln->pyro-Glu"}, {"accession": "UNIMOD:6", "name": "Carboxymethyl"}, {"accession": "UNIMOD:4", "name": "Carbamidomethyl"}, {"accession": "UNIMOD:35", "name": "Oxidation"}, {"accession": "UNIMOD:259", "name": "Label:13C(6)15N(2)"}, {"accession": "UNIMOD:267", "name": "Label:13C(6)15N(4)"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "34242034"}, {"accession": "MS:1002866", "name": "Reference", "value": "McDonald Z, Taylor P, Liyasova M, Liu Q, Ma B. Mass Spectrometry Provides a Highly Sensitive Noninvasive Means of Sequencing and Tracking M-Protein in the Blood of Multiple Myeloma Patients. J Proteome Res. 2021 Jul 9. doi: 10.1021/acs.jproteome.0c01022. Epub ahead of print. PMID: 34242034."}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "IgG M-protein quantification  by PRM in blood of multiple myeloma patient"}